Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | A |
---|---|---|
09:32 ET | 24783 | 138.31 |
09:33 ET | 1116 | 137.605 |
09:35 ET | 4591 | 137.3401 |
09:37 ET | 9689 | 137.89 |
09:39 ET | 10708 | 138.5 |
09:42 ET | 5176 | 138.34 |
09:44 ET | 28858 | 138.48 |
09:46 ET | 5346 | 138.555 |
09:48 ET | 2800 | 139.02 |
09:50 ET | 4932 | 139.27 |
09:51 ET | 8412 | 138.57 |
09:53 ET | 11977 | 138.4 |
09:55 ET | 10914 | 138.69 |
09:57 ET | 4178 | 139.21 |
10:00 ET | 6794 | 139.18 |
10:02 ET | 26755 | 139.695 |
10:04 ET | 3288 | 139.59 |
10:06 ET | 4672 | 139.68 |
10:08 ET | 11157 | 140.08 |
10:09 ET | 8467 | 140.0637 |
10:11 ET | 6303 | 140.22 |
10:13 ET | 21753 | 140.28 |
10:15 ET | 2014 | 139.95 |
10:18 ET | 2329 | 140.005 |
10:20 ET | 1715 | 139.665 |
10:22 ET | 3045 | 139.605 |
10:24 ET | 1200 | 139.77 |
10:26 ET | 2355 | 139.96 |
10:27 ET | 1786 | 139.62 |
10:29 ET | 3023 | 139.81 |
10:31 ET | 1400 | 139.875 |
10:33 ET | 2450 | 139.955 |
10:36 ET | 2844 | 139.74 |
10:38 ET | 2677 | 139.72 |
10:40 ET | 1907 | 139.86 |
10:42 ET | 300 | 139.92 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Agilent Technologies Inc | 39.3B | 29.1x | +9.42% |
Edwards Lifesciences Corp | 40.7B | 28.2x | +14.85% |
Resmed Inc | 35.9B | 32.6x | +19.48% |
Illumina Inc | 23.9B | -8.1x | --- |
Veeva Systems Inc | 34.5B | 55.2x | +17.29% |
Hologic Inc | 19.1B | 28.7x | --- |
Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Agilent CrossLab segment offers a service portfolio that includes repairs, parts, maintenance, installations and various other custom services to support the laboratory operations. It also offers contract development and manufacturing organization (CDMO) services.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $39.3B |
---|---|
Revenue (TTM) | $6.5B |
Shares Outstanding | 287.3M |
Dividend Yield | 0.67% |
Annual Dividend Rate | 0.9440 USD |
Ex-Dividend Date | 10-01-24 |
Pay Date | 10-23-24 |
Beta | 1.07 |
EPS | $4.81 |
Book Value | $20.01 |
P/E Ratio | 29.1x |
Price/Sales (TTM) | 6.1 |
Price/Cash Flow (TTM) | 23.6x |
Operating Margin | 23.56% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.